Перейти к содержанию

Penumbra Inc (PEN) stock: revenue, earnings & dividend

Penumbra Inc (PEN, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener PEN · NYSE Medizintechnik & Messgeräte US-CA

Key figures

Fiscal year
2025
Revenue
1.4 bn $
Revenue growth
17.5 %
Revenue growth 5y (p.a.)
20.2 %
Net income
178 m $
Net margin
12.7 %
Operating margin
13.5 %
Earnings per share (diluted)
4.52 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
1.83 bn $
Equity
1.43 bn $
Equity ratio
78.2 %
Return on equity
12.5 %
Cash
187 m $
Operating cash flow
239 m $
Free cash flow
175 m $
Shares outstanding
39,414,385

History

Revenue by fiscal year

2016 263 m $
2017 334 m $
2018 445 m $
2019 547 m $
2020 560 m $
2021 748 m $
2022 847 m $
2023 1.06 bn $
2024 1.19 bn $
2025 1.4 bn $

Net income by fiscal year

2016 14.8 m $
2017 4.66 m $
2018 6.6 m $
2019 48.5 m $
2020 -15.7 m $
2021 5.28 m $
2022 -2 m $
2023 91 m $
2024 14 m $
2025 178 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.4 bn $178 m $4.52 $–239 m $
20241.19 bn $14 m $0.36 $–168 m $
20231.06 bn $91 m $2.32 $–97.3 m $
2022847 m $-2 m $-0.05 $–-55.66 m $
2021748 m $5.28 m $0.14 $–9.5 m $
2020560 m $-15.7 m $-0.44 $–-33.24 m $
2019547 m $48.5 m $1.34 $–26.7 m $
2018445 m $6.6 m $0.18 $–28.8 m $
2017334 m $4.66 m $0.13 $–12.7 m $
2016263 m $14.8 m $0.44 $–-12.81 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)